Heparin Derived Oligosaccharides by Enzyme, Acid & Alkali Cleavage
 
 

Note: In each case (enzyme, acid and alkali) the predominant disaccharide unit in each fraction is shown in square brackets. However, each size class also contains oligosaccharides with the same degree of polymerisation but with variations in degree and position of sulphation. Dextra can provide custom services to subfractionate the differentially-sulphated heparin oligosaccharides in any size class-please enquire.

Heparinase I Derived Unsaturated Oligosaccharides

This group of unsaturated oligosaccharides is produced by the partial depolymerisation of Heparin using the enzyme heparinase I.  This cleaves Heparin between N-sulphated glucosamine (GlcNSO3) and 2-O-sulphated idurnate (IdoA, 2S).  This method of cleavage results in unsaturated oligosaccharides with uronate 2-O-sulphate (UA, 2S) at the non-reducing end of the fragment.  Unsaturation is present between carbons 4-5 on this terminal uronate residue.

The individual products are separated by high resolution gel permeation chromatography.


 
 ID1002
 
     Disaccharide (dp2)
 
2mg
 
 ID1004
 
     Tetrasaccharide (dp4)
 
2mg
 
 ID1006
 
     Hexasaccharide (dp6)
 
2mg
 
 ID1008
 
     Octasaccharide (dp8)
 
2mg
 
 ID1010
 
     Decasaccharide (dp10)
 
2mg
 
 ID1012
 
     Dodecasaccharide (dp12)
 
2mg
 
 ID1014
 
     Tetradecasaccharide (dp14)
 
2mg
 
 ID1016
 
     dp 16 saccharide
 
2mg
 
 ID1018
 
     dp 18saccharide
 
2mg
 
 ID1020
 
     dp 20saccharide
 
2mg
 
 ID1022
 
     dp 22saccharide
 
2mg
 
 ID1024
 
     dp 24saccharide
 
2mg
 
 ID1026
 
     dp 26saccharide
 
2mg
 
 ID1028
 
     Mixed Oligosaccharides (>dp26)
 
2mg
 
Nitrous Acid Derived Deaminated Oligosaccharides from Heparin
 

These oligosaccharides are produced by partial deaminative scission using nitrous acid.  The oligosaccharides have either uronate 2-O-sulphate (shown below) or non sulphated uronate at the non-reducing end of the fragment.  Note that the end chain uronate structure is not affected by nitrous acid but anhydromannose is produced at the reducing end, which is subsequently reduced to anhydromannitol.

Below are shown examples of the oligomeric series which can be extended in DP as for the enzyme and alkali-derived fractions.  Please enquire for availability and price of these and higher members of the series.

 ID2002
 
     Disaccharide (dp2)
 
 
 ID2004
 
     Tetrasaccharide (dp4)
 
 


 
 ID3002
 
     Disaccharide (dp2)
 
2mg
 
 ID3004
 
     Tetrasaccharide (dp4)
 
2mg
 
Alkali Derived Unsaturated Oligosaccharides from Heparin
 
These oligosaccharides are produced by the beta eliminative cleavage of the benzoyl ester of Heparin by alkali treatment.  This method of degradation is the chemical equivalent to heparinase I digestion, but lacks the specificity of the enzyme.  The resulting oligosaccharides have uronate 2-O-sulphate (as shown) or non-sulphated uronate at the non-reducing terminal.  These oligosaccharides are broadly similar to those produced by heparinase I but with potentially interesting sequence variations.  The fractions are separated by high resolution gel permeation chromatography.
 
 ID3006
 
     Hexasaccharide (dp6)
 
2mg
 
 ID3008
 
     Octasaccharide (dp8)
 
2mg
 
 ID3010
 
     Decasaccharide (dp10)
 
2mg
 
 ID3012
 
     Dodecasaccharide (dp12)
 
2mg
 
 ID3014
 
     Tetradecasaccharide (dp14)
 
2mg
 
 ID3016
 
     dp 16saccharide
 
2mg
 
 ID3018
 
     dp 18saccharide
 
2mg
 
 ID3020
 
     dp 20saccharide
 
2mg
 
 ID3022
 
     dp 22saccharide
 
2mg
 
 ID3024
 
     dp 24saccharide
 
2mg
 
 ID3026
 
     dp 26saccharide
 
2mg
 
 ID3028
 
     Mixed Oligosaccharides (>dp26)
 
2mg